Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1KCO

Structure of e131 Zeta Peptide, a Potent Antagonist of the High-Affinity IgE Receptor

Summary for 1KCO
Entry DOI10.2210/pdb1kco/pdb
Related1KCN
Descriptore131 Zeta Peptide (1 entity in total)
Functional Keywordsdisulfide-bonded, helical, "zeta" structure, protein binding
Total number of polymer chains1
Total formula weight2537.91
Authors
Nakamura, G.R.,Reynolds, M.E.,Chen, Y.M.,Starovasnik, M.A.,Lowman, H.B. (deposition date: 2001-11-09, release date: 2002-03-06, Last modification date: 2024-11-13)
Primary citationNakamura, G.R.,Reynolds, M.E.,Chen, Y.M.,Starovasnik, M.A.,Lowman, H.B.
Stable "zeta" peptides that act as potent antagonists of the high-affinity IgE receptor.
Proc.Natl.Acad.Sci.USA, 99:1303-1308, 2002
Cited by
PubMed Abstract: Recently we described a family of peptides, unrelated in sequence to IgE, that form stable beta-hairpins in solution and inhibit IgE activity in the microM range [Nakamura, G. R., Starovasnik, M. A., Reynolds, M. E. & Lowman, H. B. (2001) Biochemistry 40, 9828-9835]. Using an expanded set of peptide-phage libraries, we found a simpler motif, X(2)CPX(2)CYX, for binding to the high-affinity IgE receptor. In solution, one of these peptides spontaneously formed a covalent antiparallel dimer. We subsequently linked these monomers in a single-chain construct on phage and optimized receptor binding. Ultimately, peptides with 30 nM affinity were produced. NMR studies showed that the peptide adopts a stable fold consisting of two "zeta" (zeta)-shaped moieties. Structure-activity analyses reveal a single binding site created by the zeta-dimer, with two tyrosine residues important for structural stability and two proline residues important for Fc epsilon RI binding. The peptides inhibit histamine release from cultured cells and are extremely stable in biological fluids. The zeta peptides appear to act as competitive IgE inhibitors and suggest possibilities for design of novel IgE antagonists.
PubMed: 11830661
DOI: 10.1073/pnas.022635599
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon